However, assumptions around market share gains appear optimistic given recent performance trends. Execution risks remain elevated across both North America and Europe.

Free cash flow recovery relies primarily on profitability improvements rather than reduced investment. High spending levels leave limited room to absorb setbacks.

Additionally, competitive pressures and pricing dynamics could weigh on margins and growth delivery. Market expectations currently reflect some of these concerns.

Overall, the strategy offers potential upside but carries meaningful downside risk if targets fall short. Investors must weigh execution uncertainty against valuation support.